NEW YORK ( TheStreet) -- Shares of Medicines (Nasdaq: MDCO) were gapping up Monday morning with an open price 13% higher than Friday's closing price. The stock closed at $14.88 Friday and opened today's trading at $16.82.

The average volume for Medicines has been 466,400 shares per day over the past 30 days. Medicines has a market cap of $799.3 million and is part of the health care sector and drugs industry. Shares are up 5.3% year to date as of the close of trading on Friday.

The Medicines Company, a global pharmaceutical company, provides various medicines to hospitals for advancing the treatment of critical care patients primarily in the United States and Europe. The company has a P/E ratio of 9.5, above the average drugs industry P/E ratio of 6.9 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Medicines as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, weak operating cash flow and feeble growth in the company's earnings per share. You can view the full Medicines Ratings Report.

Get more investment ideas from our investment research center.

Interested in other stocks that are gapping up? Get free SMS text alerts sent to you when the action happens by texting UP to 95370 or select from multiple alert options.
null

If you liked this article you might like

Atlassian, AeroVironment, Granite Construction: 'Mad Money' Lightning Round

Atlassian, AeroVironment, Granite Construction: 'Mad Money' Lightning Round

The Bottom? Not So Fast: Cramer's 'Mad Money' Recap (Tuesday 2/6/18)

The Bottom? Not So Fast: Cramer's 'Mad Money' Recap (Tuesday 2/6/18)

Melinta Up After Deal for Medicines' Infectious Disease Unit -- Biotech Movers

Melinta Up After Deal for Medicines' Infectious Disease Unit -- Biotech Movers

MacroGenics Soars on Collaboration with Incyte -- Biotech Movers

MacroGenics Soars on Collaboration with Incyte -- Biotech Movers

Fight Off Complacency: Cramer's 'Mad Money' Recap (Fri 9/15/17)

Fight Off Complacency: Cramer's 'Mad Money' Recap (Fri 9/15/17)